General Information of the Compound
| Compound ID |
CP0374581
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-piperazin-1-yl-10H-imidazo[1,2-b][2]benzazepine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H18N4
|
||||||||||||||||||
| Molecular Weight |
266.348
|
||||||||||||||||||
| Canonical SMILES |
C1CN(CCN1)C1=Cc2ccccc2Cn2ccnc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H18N4/c1-2-4-14-12-20-10-7-18-16(20)15(11-13(14)3-1)19-8-5-17-6-9-19/h1-4,7,10-11,17H,5-6,8-9,12H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
NSRMKMSTPLJNHM-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C
Protein ID: PT01206, Histamine H1 receptor